Skip to content

Cancer Genetics and Genomics Laboratory

BC Cancer

  • Home
  • Hematological
    • Acute Lymphoblastic Leukemia (Ph positive)
    • Acute Myeloid Leukemia (AML)
    • Acute Promyelocytic Leukemia (APL)
      • APL – FISH (Dx)
      • APL – RT-ddPCR (MRD)
      • APL – RTPCR
    • Chimerism
    • Chronic Lymphocytic Leukemia/Lymphoma (CLL)
    • Chronic Myeloid Leukemia (CML)
      • CML – FISH (Dx)
      • CML – QRTPCR
      • CML – RTPCR
      • CML – Kinase Domain
    • Lymphoma
      • Anaplastic Large Cell
      • Burkitt
      • Follicular
      • High-Grade B-Cell
      • IRF4 B-Cell Lymphoma
      • MALT
      • Mantle Cell
      • NHL – B/T-cell Clonality
    • Lymphoid and Myeloid Neoplasm with Eosinophilia
    • Multiple Myeloma
    • Myelodysplastic Syndrome (MDS)
    • Myeloproliferative Neoplasm (MPN)
  • Solid Tumour
    • Colorectal Cancer
      • OncoPanel
      • BRAF V600
    • Lung Cancer
      • ALK FISH
      • EGFR T790M (Plasma)
      • Focus Panel
      • ROS1 FISH
    • Melanoma
      • OncoPanel
      • Focus Panel
      • BRAF V600
    • Sarcoma
      • Alveolar Rhabdomyosarcoma (ARMS)
      • Clear Cell Sarcoma
      • Dermatofibrosarcoma protuberens (DFSP)
      • Ewing Sarcoma
      • Liposarcoma
      • Low Grade Fibromyxoid Sarcoma
      • Myxoid Liposarcoma
      • Synovial Sarcoma
    • Prostate Cancer
      • OncoPanel
    • DPYD Screening
  • Hereditary
    • Mainstreamed Hereditary Cancer Testing
  • Genes/Probes/Panels
    • Hereditary Cancer Panel
    • Myeloid Panel
    • OncoPanel
    • Focus Panel
    • Gene/Probe List
  • Guidelines
    • Specimens
    • Variants
    • FAQ
  • Studies
    • ALTER
    • ctDNA Testing in Prostate Cancer (DISTINCTION)
    • PREDICTm
    • [CLOSED]
  • Requisitions
  • Updates
  • Contact

Metastatic Prostate Cancer

2022/05/25 by Ian Bosdet

The Cancer Genetics and Genomics Laboratory (CGL) at BC Cancer will begin offering tumour testing for patients with metastatic prostate cancer starting the week of May 24, 2022.  Key points regarding this new test offering are outlined in the memo below.

Prostate-Panel-Memo-FinalDownload
Categories Uncategorized
Post navigation
Acute Myeloid Leukemia MRD testing
Germline Confirmation of Pathogenic Variants Identified by Oncopanel
© 2023 Cancer Genetics and Genomics Laboratory •